National

Stocks rose Wednesday on promising new COVID-19 vaccine data from Moderna Therapeutics, although much of the optimism is outpacing the science.

Axios Re:Cap digs into what Moderna said, what it didn't say, and what comes next in the vaccine race with Richard Besser, former acting director of the CDC and current CEO of the Robert Wood Johnson Foundation.

Ex-CDC director on the vaccine race

Richard Besser digs into what we know and what we don't.

Health Care

Moderna

Business

Axios Re:Cap

Coronavirus

Stocks rose Wednesday on promising new COVID-19 vaccine data from Moderna Therapeutics, although much of the optimism is outpacing the science.Axios Re:Cap digs into what Moderna said, what it didn&#x27;t say, and what comes next in the vaccine race with Richard Besser, former acting director of the CDC and current CEO of the Robert Wood Johnson Foundation.

Podcasts

The U.S. faces a range of health care flashpoints — unaffordable drugs, opioids, vaping — as we debate whether to adopt universal care. For now, the Affordable Care Act is the law of the land, but Republicans want to issue it a final death blow.

Ex-CDC director on the vaccine race

Go deeper